-+ 0.00%
-+ 0.00%
-+ 0.00%

NeurAxis Rolls Out New Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation

Benzinga·12/19/2025 13:02:45
Listen to the news

NeurAxis, Inc. ("NeurAxis" or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation ("PENFS"). The coverage spans multiple states and represents approximately 45 million health plan members.